Related Experiment Video
Updated: Feb 2, 2026

Generation and Assembly of Virus-Specific Nucleocapsids of the Respiratory Syncytial Virus
Published on: July 27, 2021
Viral Load Dynamics and Clinical Disease Severity in Infants With Respiratory Syncytial Virus Infection
Cristina Garcia-Mauriño1, Melissa Moore-Clingenpeel2, Jessica Thomas3
1Center for Vaccines and Immunity, Nationwide Children's Hospital and The Ohio State University College of Medicine, Columbus.
Insights
Higher respiratory syncytial virus (RSV) loads at the start and a quicker decline are linked to less severe illness in children. Steroid treatment in severe RSV cases prolonged viral load decay.
Area of Science:
- Pediatrics
- Virology
- Infectious Diseases
Background:
- The relationship between respiratory syncytial virus (RSV) viral loads (VL) and clinical outcomes in children requires further definition.
- Previous studies often evaluated VLs in hospitalized children at a single time point.
- This study investigated VLs and disease severity in both outpatient and inpatient settings.
Purpose of the Study:
- To determine the association between respiratory syncytial virus (RSV) viral loads (VL) and disease severity in pediatric patients.
- To compare VLs and their decay patterns in outpatients versus inpatients, including those in the pediatric intensive care unit (PICU).
Main Methods:
- Enrolled previously healthy children with RSV infection.
- Defined disease severity by level of care (outpatient, ward, PICU) and a clinical disease severity score (CDSS).
- Measured nasopharyngeal VLs via PCR and CDSS at enrollment and daily for inpatients, analyzing VL decay using linear mixed modeling.
Main Results:
- 150 infants were enrolled; VLs were higher in outpatients than age-matched inpatients.
- Among inpatients, initial VLs were similar between ward and PICU patients.
- Excluding steroid-treated infants, ward patients had higher VLs than PICU patients; VL decay was delayed in PICU patients, particularly those on steroids.
Conclusions:
- Higher initial viral loads (VL) and faster, consistent VL decline correlate with less severe RSV disease in children.
- Prolonged VL decay and higher overall viral exposure were observed in severe RSV cases, especially in infants receiving steroids.
Background:
The association between respiratory syncytial virus (RSV) loads and clinical outcomes in children remains to be defined. In most studies, viral loads (VL) were evaluated in hospitalized children and at a single time-point. We investigated the relationship between VLs and disease severity in both outpatients and inpatients with RSV infection.
Methods:
We enrolled previously healthy children with RSV infection. Disease severity was defined by level of care (outpatients vs ward vs pediatric intensive care unit [PICU]), and a clinical disease severity score (CDSS). Nasopharyngeal VLs by polymerase chain reaction and CDSS were measured at enrollment and daily in inpatients. VL decay according to disease severity was analyzed using linear mixed modeling.
Results:
From February 2015 to March 2017, we enrolled 150 infants: 39 outpatients and 111 inpatients. VLs were higher in outpatients than in age-matched inpatients. Among inpatients, initial VLs were comparable in ward and PICU patients, and preceded the peak CDSS. However, after excluding infants treated with steroids, those hospitalized in the ward had higher VLs than infants requiring PICU care (P < .001). Dynamic analyses showed that VL decay was delayed in PICU patients, especially in those treated with steroids.
Conclusions:
Higher VLs at presentation and a faster and consistent VL decline were both associated with less severe RSV disease in children.
Summary:
Infants with less severe respiratory syncytial virus (RSV) disease had higher viral loads (VL) at presentation, and faster and consistent VL decline. Conversely, VL decay and overall viral exposure were prolonged and higher in infants severe RSV disease receiving steroids.
More Related Videos
Related Concept Videos
Viral Recombination
What are Viruses?
Viral Structure
Endocarditis II: Clinical Features of Infective Endocarditis
Chronic Kidney Disease II: Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations

